ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $646,000 | -48.8% | 100,000 | -40.3% | 3.92% | -51.0% |
| Q1 2023 | $1,262,950 | -51.2% | 167,500 | -34.4% | 7.99% | -50.0% |
| Q4 2022 | $2,587,202 | -15.2% | 255,400 | -17.2% | 15.98% | -39.2% |
| Q3 2022 | $3,052,000 | -21.2% | 308,570 | -15.2% | 26.27% | -2.7% |
| Q2 2022 | $3,874,000 | +38.9% | 363,778 | +27.2% | 26.99% | +118.0% |
| Q1 2022 | $2,789,000 | -54.3% | 286,000 | -33.0% | 12.38% | -24.4% |
| Q4 2021 | $6,106,000 | -29.2% | 426,966 | -0.8% | 16.39% | -32.1% |
| Q3 2021 | $8,625,000 | – | 430,407 | – | 24.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |